Dabigatran Etexilate recalls

9 recalls on record

Recalled by 1 agency: FDA (9).

First recall on record: April 5, 2023. Most recent: August 5, 2026.

Risk classification: Class II: 4 · Class III: 5

Recalert records 9 recalls for Dabigatran Etexilate from FDA. The earliest is dated April 5, 2023 and the latest August 5, 2026. 5 recalls are dated within the last 12 months. The most frequent categories are drug. The latest recall is Dabigatran Etexilate Capsules, 75 mg, 60-count (6x10)blister pack further packaged in a carton, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, INDIA, Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268, NDC 0904-7253-68. (D-0738-2026).

Most recent recalls

Questions about this brand

Does Dabigatran Etexilate have recalls in 2026?
Recalert records 5 recalls for Dabigatran Etexilate dated in 2026.

Do you sell Dabigatran Etexilate products? Check your whole catalog free against 80,000+ recalls.

Paste up to 100 UPCs or SKUs and see which ones match a CPSC, FDA, NHTSA or FSIS recall. No account needed.

Check my catalog free

Want it checked every night instead? Starter watches 500 SKUs for $29/month. See plans

Related brands